Elana Ben‐Akiva

Linking vaccine adjuvant mechanisms of action to function

Diverse priming outcomes under conditions of very rare precursor B cells

Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models

Highly functional and prolonged germinal center T follicular helper cell responses are associated with enhanced neutralizing antibody development

Simultaneous induction of multiple classes of broadly neutralizing antibody precursors by combination germline-targeting immunization in nonhuman primates

Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer

Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques

Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis

Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response

Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus

Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination

Controlled lipid self-assembly for scalable manufacturing of next-generation immune stimulating complexes

Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal

Highly Scalable, Closed‐Loop Synthesis of Drug‐Loaded, Layer‐by‐Layer Nanoparticles

Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment